Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 148 NOK 4.96% Market Closed
Market Cap: 2.7B NOK
Have any thoughts about
Medistim ASA?
Write Note

Intrinsic Value

The intrinsic value of one MEDI stock under the Base Case scenario is 169.88 NOK. Compared to the current market price of 148 NOK, Medistim ASA is Undervalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEDI Intrinsic Value
169.88 NOK
Undervaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medistim ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MEDI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MEDI?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Medistim ASA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Medistim ASA

Provide an overview of the primary business activities
of Medistim ASA.

What unique competitive advantages
does Medistim ASA hold over its rivals?

What risks and challenges
does Medistim ASA face in the near future?

Summarize the latest earnings call
of Medistim ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medistim ASA.

Provide P/S
for Medistim ASA.

Provide P/E
for Medistim ASA.

Provide P/OCF
for Medistim ASA.

Provide P/FCFE
for Medistim ASA.

Provide P/B
for Medistim ASA.

Provide EV/S
for Medistim ASA.

Provide EV/GP
for Medistim ASA.

Provide EV/EBITDA
for Medistim ASA.

Provide EV/EBIT
for Medistim ASA.

Provide EV/OCF
for Medistim ASA.

Provide EV/FCFF
for Medistim ASA.

Provide EV/IC
for Medistim ASA.

Show me price targets
for Medistim ASA made by professional analysts.

What are the Revenue projections
for Medistim ASA?

How accurate were the past Revenue estimates
for Medistim ASA?

What are the Net Income projections
for Medistim ASA?

How accurate were the past Net Income estimates
for Medistim ASA?

What are the EPS projections
for Medistim ASA?

How accurate were the past EPS estimates
for Medistim ASA?

What are the EBIT projections
for Medistim ASA?

How accurate were the past EBIT estimates
for Medistim ASA?

Compare the revenue forecasts
for Medistim ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medistim ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medistim ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medistim ASA compared to its peers.

Compare the P/E ratios
of Medistim ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medistim ASA with its peers.

Analyze the financial leverage
of Medistim ASA compared to its main competitors.

Show all profitability ratios
for Medistim ASA.

Provide ROE
for Medistim ASA.

Provide ROA
for Medistim ASA.

Provide ROIC
for Medistim ASA.

Provide ROCE
for Medistim ASA.

Provide Gross Margin
for Medistim ASA.

Provide Operating Margin
for Medistim ASA.

Provide Net Margin
for Medistim ASA.

Provide FCF Margin
for Medistim ASA.

Show all solvency ratios
for Medistim ASA.

Provide D/E Ratio
for Medistim ASA.

Provide D/A Ratio
for Medistim ASA.

Provide Interest Coverage Ratio
for Medistim ASA.

Provide Altman Z-Score Ratio
for Medistim ASA.

Provide Quick Ratio
for Medistim ASA.

Provide Current Ratio
for Medistim ASA.

Provide Cash Ratio
for Medistim ASA.

What is the historical Revenue growth
over the last 5 years for Medistim ASA?

What is the historical Net Income growth
over the last 5 years for Medistim ASA?

What is the current Free Cash Flow
of Medistim ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medistim ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medistim ASA

Current Assets 360.7m
Cash & Short-Term Investments 107.1m
Receivables 89.2m
Other Current Assets 164.4m
Non-Current Assets 116.2m
PP&E 59.4m
Intangibles 50.7m
Other Non-Current Assets 6.1m
Current Liabilities 81.7m
Other Current Liabilities 81.7m
Non-Current Liabilities 11.9m
Long-Term Debt 10.3m
Other Non-Current Liabilities 1.6m
Efficiency

Earnings Waterfall
Medistim ASA

Revenue
538.4m NOK
Cost of Revenue
-110.4m NOK
Gross Profit
428m NOK
Operating Expenses
-298.9m NOK
Operating Income
129.1m NOK
Other Expenses
-24.8m NOK
Net Income
104.3m NOK

Free Cash Flow Analysis
Medistim ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MEDI Profitability Score
Profitability Due Diligence

Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
72/100
Profitability
Score

Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

MEDI Solvency Score
Solvency Due Diligence

Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDI Price Targets Summary
Medistim ASA

Wall Street analysts forecast MEDI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDI is 175.44 NOK with a low forecast of 173.72 NOK and a high forecast of 180.6 NOK.

Lowest
Price Target
173.72 NOK
17% Upside
Average
Price Target
175.44 NOK
19% Upside
Highest
Price Target
180.6 NOK
22% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MEDI?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MEDI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Medistim ASA Logo
Medistim ASA

Country

Norway

Industry

Health Care

Market Cap

2.7B NOK

Dividend Yield

3.04%

Description

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

Contact

OSLO
Oslo
Okernveien 94
+4723059660.0
www.medistim.com

IPO

2004-05-28

Employees

118

Officers

CEO & President
Ms. Kari Eian Krogstad
Chief Financial Officer
Mr. Thomas Jakobsen
Vice President of Operations
Mr. Helge Borslid
Vice President of Marketing
Ms. Hæge Johanne Krogh Wetterhus
Chief Innovation Officer
Mr. Hakon Grothe
Chief Business Development Officer
Mr. Ole Arne Eiksund
Show More
President of Medistim USA Inc
Mr. Mike Farbelow
Vice President of Sales - APAC
Mr. Roger Reino Morberg
Vice President of Sales EMEA
Ms. Stephanie D'Avout Stenhagen
Managing Director of Medistim Norge AS
Mr. Ole Jorgen Robsrud
Show Less

See Also

Discover More
What is the Intrinsic Value of one MEDI stock?

The intrinsic value of one MEDI stock under the Base Case scenario is 169.88 NOK.

Is MEDI stock undervalued or overvalued?

Compared to the current market price of 148 NOK, Medistim ASA is Undervalued by 13%.

Back to Top